Delivery Order SPE2DB22D9367-SPE2DB25FSY86
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,550.16 contract is for the delivery of 4,556,534,160 units of the NEXPLANON 68 MG IMPLANTS contraceptive device. The contract has a performance period ending on March 28, 2022 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,082.93 contract is for the delivery of 4,567,950,199 units of NEXPLANON 68 MG IMPLANTS, a contraceptive product. The delivery order was awarded on April 14, 2025, with a period of performance through May 5, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,288.14 firm fixed-price contract is for the delivery of 4,566,294,320 units of the NEXPLANON 68 MG IMPLANT contraceptive. The contract has an ultimate completion date of August 26, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,144.07, is for the delivery of NEXPLANON 68 MG IMPLANTS, a prescription contraceptive device, with a completion date of January 2, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,448.80 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a completion date of December 19, 2022. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,837.40 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a type of contraceptive implant, with a completion date of October 18, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,165.86 contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive product, with a performance period ending on January 29, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,497.58, is for the delivery of 4,567,925,923 units of the NEXPLANON 68 MG IMPLANTS contraceptive device. The contract has an ultimate completion date of May 5, 2025 and was awarded on April 14, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,388.64 contract is for the delivery of 68 mg NEXPLANON implants, a type of contraceptive device. The contract has an ultimate completion date of March 14, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant $499,999,999...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,165.86 contract is for the delivery of 4,567,229,402 units of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a period of performance through March 3, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSY86Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,663.44 contract is for the delivery of 4,568,851,035 units of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a completion date of August 6, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting military health facilities worldwide. This positioning establishes DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 7/16/25 |